WFC
69
-2
MAR
59
-6
KMB
42
-3
AA
72
2
BAX
44
2
NOV
55
-3
HD
43
2
SEE
55
5
DUK
52
-3
CMA
68
-2
AZO
48
-2
NRG
52
-8
APA
59
2
APH
56
-2
INTU
65
5
GE
62
-3
FFIV
45
4
CVS
41
-3
LMT
50
3
LEG
61
-3
WFC
69
-2
MAR
59
-6
KMB
42
-3
AA
72
2
BAX
44
2
NOV
55
-3
HD
43
2
SEE
55
5
DUK
52
-3
CMA
68
-2
AZO
48
-2
NRG
52
-8
APA
59
2
APH
56
-2
INTU
65
5
GE
62
-3
FFIV
45
4
CVS
41
-3
LMT
50
3
LEG
61
-3
Financhill
Back

Sartorius Stedim Biotech SA 10K Form

Buy
69

SDMHF
Sartorius Stedim Biotech SA

Last Price:
$247.25
Seasonality Move:
2.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SDMHF News And Ratings

See the #1 stock for the next 7 days that we like better than SDMHF

SDMHF Financial Statistics

Sales & Book Value

Annual Sales: $3B
Cash Flow: $-83.8M
Price / Cash Flow: 105.02
Annual Sales: $48.74
Price / Book: 5.07

Profitability

EPS (TTM): 2.99540
Net Income (TTM): $292.7M
Gross Margin: $1.3B
Return on Equity: 6.53%
Return on Assets: 3.22%

Sartorius Stedim Biotech SA Earnings Forecast

Key Sartorius Stedim Biotech SA Financial Ratios

  • The Gross Profit Margin over the past 20 years for SDMHF is 43.41%.
  • The Selling, General & Administrative Expenses for SDMHF have been equal to 23.33% of Gross Profit Margin.
  • The Research & Development expenses have been 4.91% of Revenue.
  • The Interest Expense is 89.02% of Operating Income.
  • The Net Earning history of SDMHF is 6.42% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 16 years.

Sartorius Stedim Biotech SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: SDMHF
Website: sartorius.com

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 1.05
Quick Ratio: 0.4

Price-to-Earnings

Trailing P/E Ratio: 126.33
Forward P/E Ratio: 0

SDMHF Technical Analysis vs Fundamental Analysis

Buy
69
Sartorius Stedim Biotech SA (SDMHF) is a Buy

Is Sartorius Stedim Biotech SA a Buy or a Sell?